AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

The Master of Science degree program in Drug Discovery & Development (DDD ... and pharmacogenomics. Working in project teams, students get practical experience implementing strategies. Both full-time ...

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of high-quality, objective advice on science, engineering, and health matters. Top experts participate ...

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Targeted therapies for high-risk leukemia in children have yet to be developed, but scientists at Université de Montréal and ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...